Literature DB >> 9617989

Alprazolam is another substrate for human cytochrome P450-3A isoforms.

K Venkatakrishnan, D J Greenblatt, L L von Moltke, R I Shader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9617989     DOI： 10.1097/00004714-199806000-00015

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  9 in total

Review 1.  A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.

Authors:  Andrew Stolbach; Karolina Paziana; Harry Heverling; Paul Pham
Journal:  J Med Toxicol       Date:  2015-09

Review 2.  Pharmacokinetics of haloperidol: an update.

Authors:  S Kudo; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 3.  Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.

Authors:  Dhananjay Pal; Deep Kwatra; Mukul Minocha; Durga K Paturi; Balasubrahmanyam Budda; Ashim K Mitra
Journal:  Life Sci       Date:  2010-11-01       Impact factor: 5.037

4.  Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity.

Authors:  T Fukasawa; N Yasui-Furukori; A Suzuki; Y Inoue; T Tateishi; K Otani
Journal:  Eur J Clin Pharmacol       Date:  2005-11-01       Impact factor: 2.953

Review 5.  Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem.

Authors:  G Chouinard; K Lefko-Singh; E Teboul
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

Review 6.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 7.  MDR- and CYP3A4-mediated drug-drug interactions.

Authors:  Dhananjay Pal; Ashim K Mitra
Journal:  J Neuroimmune Pharmacol       Date:  2006-08-02       Impact factor: 4.147

8.  Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters.

Authors:  Kelly Bleasby; Robert Houle; Michael Hafey; Meihong Lin; Jingjing Guo; Bing Lu; Rosa I Sanchez; Kerry L Fillgrove
Journal:  Viruses       Date:  2021-08-07       Impact factor: 5.048

9.  Population-based screening to detect benzodiazepine drug-drug-drug interaction signals associated with unintentional traumatic injury.

Authors:  Cheng Chen; Sean Hennessy; Colleen M Brensinger; Emily K Acton; Warren B Bilker; Sophie P Chung; Ghadeer K Dawwas; John R Horn; Todd A Miano; Thanh Phuong Pham Nguyen; Charles E Leonard
Journal:  Sci Rep       Date:  2022-09-16       Impact factor: 4.996
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.